Berg D - Search Results

1

Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease.

Krüger R, Menezes-Saecker AM, Schöls L, Kuhn W, Müller T, Woitalla D, Berg D, Berger K, Przuntek H, Epplen JT, Riess O. Krüger R, et al. Among authors: berg d. Neuroreport. 2000 Aug 3;11(11):2439-42. doi: 10.1097/00001756-200008030-00020. Neuroreport. 2000. PMID: 10943700

2

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.

Krüger R, Vieira-Saecker AM, Kuhn W, Berg D, Müller T, Kühnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: berg d. Ann Neurol. 1999 May;45(5):611-7. doi: 10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x. Ann Neurol. 1999. PMID: 10319883

3

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.

Wintermeyer P, Krüger R, Kuhn W, Müller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schöls L, Epplen JT, Riess O. Wintermeyer P, et al. Among authors: berg d. Neuroreport. 2000 Jul 14;11(10):2079-82. doi: 10.1097/00001756-200007140-00004. Neuroreport. 2000. PMID: 10923647

4

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.

Krüger R, Hardt C, Tschentscher F, Jäckel S, Kuhn W, Müller T, Werner J, Woitalla D, Berg D, Kühnl N, Fuchs GA, Santos EJ, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: berg d. J Neural Transm (Vienna). 2000;107(5):553-62. doi: 10.1007/s007020070078. J Neural Transm (Vienna). 2000. PMID: 11072751

5

Cognitive response control in writer's cramp.

Berg D, Herrmann MJ, Müller TJ, Strik WK, Aranda D, Koenig T, Naumann M, Fallgatter AJ. Berg D, et al. Eur J Neurol. 2001 Nov;8(6):587-94. doi: 10.1046/j.1468-1331.2001.00298.x. Eur J Neurol. 2001. PMID: 11784343

6

14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.

Ubl A, Berg D, Holzmann C, Krüger R, Berger K, Arzberger T, Bornemann A, Riess O. Ubl A, et al. Among authors: berg d. Brain Res Mol Brain Res. 2002 Dec;108(1-2):33-9. doi: 10.1016/s0169-328x(02)00510-7. Brain Res Mol Brain Res. 2002. PMID: 12480176

7

Iron in neurodegenerative disorders.

Berg D, Becker G, Riederer P, Riess O. Berg D, et al. Neurotox Res. 2002 Nov-Dec;4(7-8):637-653. doi: 10.1080/1029842021000045444. Neurotox Res. 2002. PMID: 12709302

8

Therapeutic strategies for Parkinson's disease based on data derived from genetic research.

Riess O, Berg D, Krüger R, Schulz JB. Riess O, et al. Among authors: berg d. J Neurol. 2003 Feb;250 Suppl 1:I3-10. doi: 10.1007/s00415-003-1101-3. J Neurol. 2003. PMID: 12761628 Review.

9

Specification of 14-3-3 proteins in Lewy bodies.

Berg D, Riess O, Bornemann A. Berg D, et al. Ann Neurol. 2003 Jul;54(1):135. doi: 10.1002/ana.10621. Ann Neurol. 2003. PMID: 12838532 No abstract available.

10

14-3-3 proteins in the nervous system.

Berg D, Holzmann C, Riess O. Berg D, et al. Nat Rev Neurosci. 2003 Sep;4(9):752-62. doi: 10.1038/nrn1197. Nat Rev Neurosci. 2003. PMID: 12951567 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,419 results

Search Page

Filters